Edition:
United States

Nymox Pharmaceutical Corp (NYMX.OQ)

NYMX.OQ on NASDAQ Stock Exchange Capital Market

1.69USD
23 Aug 2019
Change (% chg)

$-0.04 (-2.31%)
Prev Close
$1.73
Open
$1.72
Day's High
$1.73
Day's Low
$1.66
Volume
10,743
Avg. Vol
52,473
52-wk High
$2.85
52-wk Low
$1.25

About

Nymox Pharmaceutical Corp is a Canada-based biopharmaceutical company. The Company is focused on developing its drug candidate, NX-1207, for the treatment of benign prostatic hyperplasia (BPH) and the treatment of low-grade localized prostate cancer. The Company operates through the research and development of products for the... (more)
No analyst recommendations are available for .

Overall

Beta: 1.79
Market Cap(Mil.): $108.66
Shares Outstanding(Mil.): 64.68
Dividend: --
Yield (%): --

Financials

  NYMX.OQ Industry Sector
P/E (TTM): -- 98.31 33.85
EPS (TTM): -0.17 -- --
ROI: -231.59 7.52 12.69
ROE: -238.81 7.94 17.13
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates